Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinomaGloria Peiró, Enrique Lerma|British Journal of Cancer|2014Cited by 94
Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcomeGloria Peiró, Joachim Diebold|Modern Pathology|2004Cited by 60
High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtypeYoel Genaro Montoyo-Pujol, Gloria Peiró|Research Square|2024Cited by 1